Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Contrast enhancement ultrasonography(CEUS)could be used to evaluate the blood flow perfusion liver cancer. In this clinical trial, CEUS was used to evaluated the changes of blood flow perfusion of Secondary Malignant Neoplasm of Liver after treated with endostatin plus paclitaxel and carboplatin regimen.
Epistemonikos ID: 0731bee7c031db14b453ffb146922c0542d31e1b
First added on: May 06, 2024